87 related articles for article (PubMed ID: 15802347)
1. Angiotensin II antagonism fails to ameliorate bleomycin-induced pulmonary fibrosis in mice.
Keogh KA; Standing J; Kane GC; Terzic A; Limper AH
Eur Respir J; 2005 Apr; 25(4):708-14. PubMed ID: 15802347
[TBL] [Abstract][Full Text] [Related]
2. Losartan attenuates bleomycin-induced pulmonary fibrosis in rats.
Yao HW; Zhu JP; Zhao MH; Lu Y
Respiration; 2006; 73(2):236-42. PubMed ID: 16330873
[TBL] [Abstract][Full Text] [Related]
3. [Perindopril and losartan attenuate bleomycin A5-induced pulmonary fibrosis in rats].
Meng Y; Meng Y; Li X; Cai SX; Tong WC; Cheng YX
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):919-24. PubMed ID: 18583228
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin-angiotensin system in the lung.
Chang J; Nie H; Ge X; Du J; Liu W; Li X; Sun Y; Wei X; Xun Z; Li YC
Sci Rep; 2021 Aug; 11(1):16525. PubMed ID: 34400742
[TBL] [Abstract][Full Text] [Related]
5. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
Izumo T; Kondo M; Nagai A
Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
[TBL] [Abstract][Full Text] [Related]
6. Losartan attenuates paraquat-induced pulmonary fibrosis in rats.
Guo F; Sun YB; Su L; Li S; Liu ZF; Li J; Hu XT; Li J
Hum Exp Toxicol; 2015 May; 34(5):497-505. PubMed ID: 25233898
[TBL] [Abstract][Full Text] [Related]
7. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
[TBL] [Abstract][Full Text] [Related]
8. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
9. [Effect of losartan on lung fibrosis in neonatal rats with hyperoxia-induced chronic lung disease].
Chen N; Li JJ; Xue XD
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):591-4. PubMed ID: 18082049
[TBL] [Abstract][Full Text] [Related]
10. The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis.
Königshoff M; Wilhelm A; Jahn A; Sedding D; Amarie OV; Eul B; Seeger W; Fink L; Günther A; Eickelberg O; Rose F
Am J Respir Cell Mol Biol; 2007 Dec; 37(6):640-50. PubMed ID: 17630322
[TBL] [Abstract][Full Text] [Related]
11. [Losartan in the rat model of bleomycin-induced pulmonary fibrosis and its impact on the expression of monocyte chemoattractant protein-1 and basic fibroblast growth factor].
Fang X; Zhu Y; Hu X; Liu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2002 May; 25(5):268-72. PubMed ID: 12133317
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 1 receptor antagonist attenuates lung fibrosis in hyperoxia-exposed newborn rats.
Chou HC; Lang YD; Wang LF; Wu TY; Hsieh YF; Chen CM
J Pharmacol Exp Ther; 2012 Jan; 340(1):169-75. PubMed ID: 22005041
[TBL] [Abstract][Full Text] [Related]
14. Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis.
Molina-Molina M; Serrano-Mollar A; Bulbena O; Fernandez-Zabalegui L; Closa D; Marin-Arguedas A; Torrego A; Mullol J; Picado C; Xaubet A
Thorax; 2006 Jul; 61(7):604-10. PubMed ID: 16601095
[TBL] [Abstract][Full Text] [Related]
15. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
16. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
17. Essential roles for angiotensin receptor AT1a in bleomycin-induced apoptosis and lung fibrosis in mice.
Li X; Rayford H; Uhal BD
Am J Pathol; 2003 Dec; 163(6):2523-30. PubMed ID: 14633624
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
El-Medany A; Hagar HH; Moursi M; At Muhammed R; El-Rakhawy FI; El-Medany G
Eur J Pharmacol; 2005 Feb; 509(1):61-70. PubMed ID: 15713430
[TBL] [Abstract][Full Text] [Related]
19. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
El-Lakkany NM; El-Maadawy W; Ain-Shoka A; Badawy A; Hammam O; Ebeid F
Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):695-704. PubMed ID: 21762203
[TBL] [Abstract][Full Text] [Related]
20. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
Fraune C; Lange S; Krebs C; Hölzel A; Baucke J; Divac N; Schwedhelm E; Streichert T; Velden J; Garrelds IM; Danser AH; Frenay AR; van Goor H; Jankowski V; Stahl R; Nguyen G; Wenzel UO
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1037-48. PubMed ID: 22791343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
